Highlights from the 2017 St. Gallen Breast Cancer Consensus
Sign Up to like & getrecommendations! Published in 2017 at "memo - Magazine of European Medical Oncology"
DOI: 10.1007/s12254-017-0349-x
Abstract: Three topics on endocrine therapy of preand postmenopausal patients with hormone-receptor positive breast cancer were discussed in detail: ovarian function suppression (OFS), aromoatase inhibitors (AI) and extended endocrine therapy. The panel acknowledged that patients below… read more here.
Keywords: endocrine therapy; extended endocrine; therapy; breast cancer ... See more keywords
Identify high risk estrogen receptor-positive breast cancer patients for extended endocrine therapy.
Sign Up to like & getrecommendations! Published in 2017 at "Breast"
DOI: 10.1016/j.breast.2016.11.008
Abstract: PURPOSE To demonstrate the patterns of breast cancer-specific mortality (BCSM) in estrogen receptor (ER)-positive diseases and to identify high-risk candidates for extended endocrine therapy. METHODS Using the Surveillance, Epidemiology and End Results database, we identified… read more here.
Keywords: extended endocrine; endocrine therapy; risk group; risk ... See more keywords